What changed against expectations was pricing power rather than the revenue line, and the open question is how fast scale turns into margin against the cost of the debt behind the build. CoreWeave (CRWV) reported Q2 FY2026 after the close on August 11, and the stock rose 19.3% on the first trading day after the report. The quarter's real evidence sits further down the income statement, in an adjusted operating line that turned, and in the interest bill beneath it.
The $128 Million Line, Not The $2.58 Billion One Revenue of $2.58 billion landed between two published consensus figures, $2.56 billion and $2.61 billion, and the loss of $1.03 a share beat the $1.24 expected. Neither line explains a move of that size. What changed shape is adjusted operating income of $128 million, above the high end of management's own guidance and up from $21 million in Q1 FY2026, though still short of the $200 million CoreWeave earned a year earlier.
CoreWeave added close to 500 megawatts of active power in the quarter, more than in any quarter of its history, and most of it arrived only in June. The cost is in the reported quarter; management says the revenue lands in the second half of 2026. Sold-Out Capacity Is Now Setting The Price Price is the lever that inflected.
Management says near-term capacity is effectively sold out, and in July the company pushed through an approximately 25% price increase across SKUs. Even before that, contracts signed during the quarter carried contribution margins management expects to run 5 to 10 percentage points above recent ones. Much of that step sits in the Vera Rubin SKU, the NVIDIA generation CoreWeave says it validated first.
Older silicon is holding its price too: management points to an A100 contract, a 2020 architecture, written out to 2029. The managed inference platform, launched months ago, is held back by capacity, not demand. The Interest Bill Is Outrunning The Operating Line The capacity build is financed largely with debt.
Net loss widened to $626 million from $290 million a year earlier as interest expense more than doubled to $640 million. The guide makes the shape plain: management expects Q3 FY2026 interest expense of $860 million to $940 million, roughly three to five times the adjusted operating income of $200 million to $260 million guided for the same quarter. Funding risk of that shape is why the Trefis High Quality Portfolio insists on defensible balance sheets in its holdings.
Extract — continue reading at the source.
